Cargando…
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
BACKGROUND/AIM: The aim of our study was to compare the efficacy and the safety of the FLOT and the modified DCF (mDCF) regimens in patients with metastatic gastric (GC) and gastroesophageal junction (GEJ) adenocarcinoma as first-line treatment. MATERIALS AND METHODS: The medical records of 72 patie...
Autores principales: | GÜRLER, Fatih, GÜVEN, Deniz Can, AYDEMİR, Ergin, SÜTÇÜOĞLU, Osman, KURT İNCİ, Bediz, ARIK, Zafer, YALÇIN, Şuayib, ÖZDEMİR, Nuriye, ÖZET, Ahmet, YAZICI, Ozan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395706/ https://www.ncbi.nlm.nih.gov/pubmed/36422493 http://dx.doi.org/10.55730/1300-0144.5496 |
Ejemplares similares
-
The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective
por: SÜTCÜOĞLU, Osman, et al.
Publicado: (2022) -
Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2
por: Ünsal, Oktay, et al.
Publicado: (2021) -
Efficacy and safety of FLOT regimen vs DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east
por: Farrokhi, Pegah, et al.
Publicado: (2022) -
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
por: EROL, Cihan, et al.
Publicado: (2022) -
The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma
por: Aslan, Volkan, et al.
Publicado: (2023)